Skip to main content
Caplight Logo









Bioceltech Therapeutics, Ltd.

Bioceltech Therapeutics, Ltd.

Private
BeijingHealthcare & Life Scienceshttp://bioceltech.com/

Last Round

Series A

Jun 2, 2023

Total Funding Raised

$8M

Company Overview

Bioceltech Therapeutics, Ltd. is a biotechnology company that focuses on the development and application of immunotherapy, including CAR-T cell therapies for the treatment of hematologic neoplasms and solid tumors.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

cell therapyCAR-Tregenerative medicinebiopharmaceutical R&Dclinical trialsimmunotherapygene engineeringbiotech startupimmune function inspectionclinical-stage biotechcell-based therapyadvanced therapies

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Bioceltech Therapeutics, Ltd. Comparables

Compare Bioceltech Therapeutics, Ltd. with similar companies based on industry and business-model similarity.

Bioceltech Therapeutics, Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Sichuan Neo-Immunotech Co., Ltd.
79%
Juventas Cell Therapy Ltd.
79%
AbelZeta Pharma
78%

Bioceltech Therapeutics, Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJun 2, 2023
AngelJan 4, 2018

Bioceltech Therapeutics, Ltd. Investors

Notable investors and investment history

Bioceltech Therapeutics, Ltd. investors
InvestorRounds
CanicaSeries A
SandwaterSeries A
Anlong FundAngel

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 2, 2023

    Raised $8M with participation from Canica and Sandwater.

  • Jan 4, 2018

    Anlong Fund participated in the Angel round.

Bioceltech Therapeutics, Ltd. Filings

Explore SEC and related filing metadata, where available.

Bioceltech Therapeutics, Ltd. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Bioceltech Therapeutics, Ltd.'s valuation, stock price, and market status.

Is Bioceltech Therapeutics, Ltd. a public or private company?

Bioceltech Therapeutics, Ltd. is a private company.

What is the current stock price of Bioceltech Therapeutics, Ltd.?

Bioceltech Therapeutics, Ltd. is a private company with no public stock price. No recent secondary market data is available.

How much is Bioceltech Therapeutics, Ltd. worth (valuation)?

Valuation information for Bioceltech Therapeutics, Ltd. is not publicly available.

Can I buy Bioceltech Therapeutics, Ltd. stock?

Bioceltech Therapeutics, Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Bioceltech Therapeutics, Ltd.'s last funding round?

Bioceltech Therapeutics, Ltd.'s most recent funding round was Series A on June 2, 2023.

Who are the main investors in Bioceltech Therapeutics, Ltd.?

Key investors in Bioceltech Therapeutics, Ltd. include Canica, Sandwater, Anlong Fund.

Will Bioceltech Therapeutics, Ltd. IPO soon?

No public IPO plans have been announced for Bioceltech Therapeutics, Ltd..

How can I track Bioceltech Therapeutics, Ltd. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Bioceltech Therapeutics, Ltd.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBeijing
Year Founded2017
Last FundingJun 2, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?